- Home
- XNCR vs WLKP Comparison
XNCR vs WLKP Comparison
Compare XNCR & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | WLKP |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 756.4M |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | XNCR | WLKP |
|---|---|---|
| Price | $10.82 | $21.55 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $22.78 | N/A |
| AVG Volume (30 Days) | ★ 683.5K | 48.8K |
| Earning Date | 02-26-2026 | 02-23-2026 |
| Dividend Yield | N/A | ★ 8.65% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.39 |
| Revenue | $150,132,000.00 | ★ $1,133,706,000.00 |
| Revenue This Year | $18.68 | $3.88 |
| Revenue Next Year | N/A | $12.71 |
| P/E Ratio | ★ N/A | $15.63 |
| Revenue Growth | ★ 38.16 | N/A |
| 52 Week Low | $6.92 | $17.75 |
| 52 Week High | $18.69 | $25.04 |
Technical Indicators
Market Signals| Indicator | XNCR | WLKP |
|---|---|---|
| Relative Strength Index (RSI) | 26.26 | 63.34 |
| Support Level | $11.82 | $21.03 |
| Resistance Level | $12.44 | $22.30 |
| Average True Range (ATR) | 0.72 | 0.40 |
| MACD | -0.12 | 0.01 |
| Stochastic Oscillator | 1.34 | 54.34 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About WLKP Westlake Chemical Partners LP
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.